Long-Acting Anti-HIV Drugs Targeting HIV-1 Reverse Transcriptase and Integrase

One of the major factors contributing to HIV-1 drug resistance is suboptimal adherence to combination antiretroviral therapy (cART). Currently, recommended cART for HIV-1 treatment is a three-drug combination, whereas the pre-exposure prophylaxis (PrEP) regimens consist of one or two antivirals. Tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Kamal, Sarafianos, Stefan G., Sönnerborg, Anders
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6631967/
https://www.ncbi.nlm.nih.gov/pubmed/31010004
http://dx.doi.org/10.3390/ph12020062

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6631967/
https://www.ncbi.nlm.nih.gov/pubmed/31010004
http://dx.doi.org/10.3390/ph12020062

Ejemplares similares